Express

Stock of Sorrento Therapeutics Increased by 178% After the Company Claimed Finding COVID-19 Antibody

Yiran Dai

Summary: Sorrento Therapeutics’ stock has spiked up by 178% since the biotechnology company announced the finding of a COVID-19 antibody on May 15. Sorrento’s stock closed at $2.62 Thursday afternoon and is trading at $7.30, as of the writing. The stock hit $7.62 earlier today at 12:30 pm (EST).

Sorrento Therapeutics’ stock has spiked up by 178% since the biotechnology company announced the finding of a COVID-19 antibody on May 15. Sorrento’s stock closed at $2.62 Thursday afternoon and is trading at $7.30, as of the writing. The stock hit $7.62 earlier today at 12:30 pm (EST).

In the announcement, Sorrento Therapeutics claimed the antibody has demonstrated in preclinical experiments complete inhibition of the SARS-CoV-2 virus infection of healthy cells in four days incubation. The antibody is now being submitted to a peer-reviewed publication.

According to Bitpush Covid-19 Real-time Data, worldwide confirmed cases of COVID-19 has reached 4.5 million. The US ranks top on the list with 1.42 million confirmed cases and 86,386 deaths.

By Yiran Dai

  • Silicon Valley Giants, Trump Ally Launch 'Crypto Bank' Erebor, Aiming to Fill SVB Void 7 hours ago
  • From Data Rights to Digital Property: Whistleblower Brittany Kaiser on Blockchain, RWA,... 6 days ago
  • The Base Chain's Ascent: How Deep Coinbase Integration and JPMorgan's Pilot Are Reshapi... 12 days ago
  • Tether in Trouble? U.S. Senate Just Passed a Law That Could Dethrone the $155B Stableco... 15 days ago
  • Justin Sun's Nasdaq Gamble: How Six Years Forged Ties with the Trump Family 16 days ago
  • You need to login to comment.